Expert Evaluation of Pharmacovigilance System Documents Included in the Registration Dossier
The Russian Federation and the member states of the Eurasian Economic Union (EAEU) are working on the creation of a common pharmaceutical market. EAEU marketing authorisation may be granted to those pharmaceutical companies whose activities comply with the Good Pharmacovigilance Practice (GVP). The...
Saved in:
| Main Authors: | I. I. Snegireva, E. O. Zhuravleva, N. Yu. Velts |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2020-12-01
|
| Series: | Безопасность и риск фармакотерапии |
| Subjects: | |
| Online Access: | https://www.risksafety.ru/jour/article/view/195 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Submission of Documents on the Pharmacovigilance System as Part of the Registration Dossier within the Framework of the EAEU Procedures: Analysis of Requirements and Typical Errors
by: N. Yu. Velts, et al.
Published: (2024-10-01) -
Risk Management Plan: An Expert Analysis of Changes to the EAEU Good Pharmacovigilance Practice Requirements for the Content and Submission of the Document
by: T. M. Bukatina, et al.
Published: (2023-03-01) -
Analysis of Errors Identified during Regulatory Review of Risk Management Plans Submitted as Part of Registration Dossiers
by: A. O. Lovkova, et al.
Published: (2023-12-01) -
Typical pharmacovigilance system master file (PSMF)
by: B. K. Romanov, et al.
Published: (2018-02-01) -
Review of the monograph by Kolbin A. S., Zyryanov S. K., Belousov D. Yu. "Pharmacovigilance" 2025
by: V. I. Petrov
Published: (2025-01-01)